hims semaglutide results Despite the Stigma, & Hers Isn't Backing Away From Weight-Loss Drugs Hims Online GLP-1 Clinic Review:

The FDA has reported 392 adverse events with compounded semaglutide and 215 with compounded tirzepatide, including multiple hospitalisations from dosing errors

Expected results: 6-10 lbs lean tissue gain over 6 weeks, significant strength improvements, enhanced recovery allowing increased training volume

Participants in the oral semaglutide arm underwent a dose-escalation schedule (3 mg daily for 4 weeks, followed by 7 mg daily for 4 weeks, then 14 mg daily for the remainder of the trial) to minimize gastrointestinal side effects

A subset of patients (roughly 18%) report that the weekly injection protocol stops working around week 10-12

An already-elevated baseline IGF-1 is a reason not to push the axis higher, and because GH antagonizes insulin, glucose handling deserves attention in patients with diabetes or prediabetes